X
Pharma Advancement
  • Home
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development
    Pfizer Invests Half Billion Dollars to Advance State-of-the-Art Gene Therapy Facility

    Breakthrough Cell & Gene Therapies To Transform Healthcare

    Membrane Fouling Prevention In SP - TFF Through PAT Approach

    Membrane Fouling Prevention In SP – TFF Through PAT Approach

    Sorrento and Mount Sinai Team Up for Antibody Cocktail COVI-SHIELD Project

    Making The Right CDMO Choice For Novel Antibody Creation

    AI Unveils Novel Treatment Pathways In Biomedical Research

    AI Unveils Novel Treatment Pathways In Biomedical Research

    Care Access Research Launches Alliance to Provide Infrastructure for COVID-19 Trials

    Biomedical Research Sector In Australia All Set To Expand

    Japan, Norway Partner To Strengthen Global Pandemic Response

    Japan, Norway Partner To Strengthen Global Pandemic Response

    CRO Market Outlook: Growth Potential & Regulatory Obstacles

    As Medical Uses Cope Up, Genomic Studies Reap Scale Benefits

    Centogene, Lifera Join Forces To Improve Multiomic Testing

    EU Pharma Legislation Reform Aims For Affordable Medicines

  • Manufacturing
  • Supply Chain
  • Facilities
  • Health & Nutrition
  • Events
  • Contact Us
No Result
View All Result
  • Home
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development
    Pfizer Invests Half Billion Dollars to Advance State-of-the-Art Gene Therapy Facility

    Breakthrough Cell & Gene Therapies To Transform Healthcare

    Membrane Fouling Prevention In SP - TFF Through PAT Approach

    Membrane Fouling Prevention In SP – TFF Through PAT Approach

    Sorrento and Mount Sinai Team Up for Antibody Cocktail COVI-SHIELD Project

    Making The Right CDMO Choice For Novel Antibody Creation

    AI Unveils Novel Treatment Pathways In Biomedical Research

    AI Unveils Novel Treatment Pathways In Biomedical Research

    Care Access Research Launches Alliance to Provide Infrastructure for COVID-19 Trials

    Biomedical Research Sector In Australia All Set To Expand

    Japan, Norway Partner To Strengthen Global Pandemic Response

    Japan, Norway Partner To Strengthen Global Pandemic Response

    CRO Market Outlook: Growth Potential & Regulatory Obstacles

    As Medical Uses Cope Up, Genomic Studies Reap Scale Benefits

    Centogene, Lifera Join Forces To Improve Multiomic Testing

    EU Pharma Legislation Reform Aims For Affordable Medicines

  • Manufacturing
  • Supply Chain
  • Facilities
  • Health & Nutrition
  • Events
  • Contact Us
No Result
View All Result
Pharma Advancement
No Result
View All Result
Home Drug Development

Cell And Gene Therapy Boost With Novel UK Biotech Centres

Content Team by Content Team
18th March 2023
in Drug Development, Featured, News

The National Health Service Blood and Transplant from the UK, which takes care of blood as well as platelet donations as well as organ, stem cell, and tissue transplants in the country, has come up with a new clinical biotech centre so as to boost the UK’s capacity when it comes to making DNA plasmids as well as viral vectors.

The facility, which is going to be located in North Bristol at Filton Road, is going to be a part of the effort to overcome the nation’s limited capacity to produce the materials that are needed for gene therapies as well as genetically modified cell therapies, as per the agency. The facility is also going to support preclinical work and early-phase clinical trials.

This will help cutting-edge research with the capacity to develop cures when it comes to certain critical diseases that, as of now, can only be treated and are often proven to be fatal, according to NHSBT’s director of cell, apheresis, and gene therapies, Lilian Hook.
Apparently, the site has been constructed with the help of a government grant amounting to 10 million pounds, or $10.7 million.

Because of the COVID-19 pandemic that hit the world in early 2020, the demand for new as well as innovative cell and gene therapies has skyrocketed, thereby triggering a requirement for more cell therapy production facilities. Before the pandemic, the UK government had gone on to form a Cell and Gene Therapy Catapult in 2012, which happened to be in response to the diminishing number of pharmaceutical manufacturing sites across the country. Thereafter, in 2015, the group announced that it would build an $85 million manufacturing facility to boost the biotech capacities of the country. The present NHSBT site isn’t related to that program.

Previous Post

US President Looks To Double The Drugs For Price Negotiation

Next Post

SVB Collapse And Its Implications On Biotechnology Sector

Related Posts

Pfizer Invests Half Billion Dollars to Advance State-of-the-Art Gene Therapy Facility
News

Breakthrough Cell & Gene Therapies To Transform Healthcare

13th July 2023
Pharma Innovations of 2022- A World Pharma Today Round Table
Middle East and South Asia

Technology And Policy To Drive Biopharma And Medtech Growth

12th July 2023
Membrane Fouling Prevention In SP - TFF Through PAT Approach
News

Membrane Fouling Prevention In SP – TFF Through PAT Approach

12th July 2023
Sorrento and Mount Sinai Team Up for Antibody Cocktail COVI-SHIELD Project
Drug Development

Making The Right CDMO Choice For Novel Antibody Creation

12th July 2023
AI Unveils Novel Treatment Pathways In Biomedical Research
Drug Development

AI Unveils Novel Treatment Pathways In Biomedical Research

11th July 2023
Care Access Research Launches Alliance to Provide Infrastructure for COVID-19 Trials
News

Biomedical Research Sector In Australia All Set To Expand

10th July 2023
Next Post

SVB Collapse And Its Implications On Biotechnology Sector

Latest News

Pfizer Invests Half Billion Dollars to Advance State-of-the-Art Gene Therapy Facility
News

Breakthrough Cell & Gene Therapies To Transform Healthcare

13th July 2023
Pharma Innovations of 2022- A World Pharma Today Round Table
Middle East and South Asia

Technology And Policy To Drive Biopharma And Medtech Growth

12th July 2023
Membrane Fouling Prevention In SP - TFF Through PAT Approach
News

Membrane Fouling Prevention In SP – TFF Through PAT Approach

12th July 2023
Sorrento and Mount Sinai Team Up for Antibody Cocktail COVI-SHIELD Project
Drug Development

Making The Right CDMO Choice For Novel Antibody Creation

12th July 2023
AI Unveils Novel Treatment Pathways In Biomedical Research
Drug Development

AI Unveils Novel Treatment Pathways In Biomedical Research

11th July 2023
Pharma Advancement

About Us

Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.

Qucik Links

  • Drug Development
  • Manufacturing
  • News
  • Events & Conferences
  • Newsletter Archive

Resources

  • Advertise with us
  • Contact Us
  • Download Mediapack

System

  • Search
  • Sitemap
  • RSS Feed

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

No Result
View All Result
  • Home
  • Drug Development
  • Manufacturing
  • Supply Chain
  • Facilities
  • Health & Nutrition
  • Events
  • Contact Us

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

Login to your account below

Forgotten Password?

Fill the forms bellow to register

All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In